Download - The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention
![Page 1: The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention](https://reader036.vdocuments.us/reader036/viewer/2022062323/5681619a550346895dd14f74/html5/thumbnails/1.jpg)
The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes
Prevention
Featured Article:
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP*
Diabetes Care Volume 35: 723-730
April, 2012
![Page 2: The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention](https://reader036.vdocuments.us/reader036/viewer/2022062323/5681619a550346895dd14f74/html5/thumbnails/2.jpg)
Study Objective
• Diabetes Prevention Program (DPP) and its Outcomes Study
(DPPOS) demonstrated that either intensive lifestyle intervention or metformin could prevent type 2 diabetes in high-risk adults for at least 10 years after randomization
• Study reports 10-year within-trial cost-effectiveness of the
interventions
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP* et al. Diabetes Care 2012;35:723-730
![Page 3: The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention](https://reader036.vdocuments.us/reader036/viewer/2022062323/5681619a550346895dd14f74/html5/thumbnails/3.jpg)
Study Design
• Data on resource utilization, cost, and quality of life collected prospectively
• Economic analyses were performed from health system and
societal perspectives
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP* et al. Diabetes Care 2012;35:723-730
![Page 4: The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention](https://reader036.vdocuments.us/reader036/viewer/2022062323/5681619a550346895dd14f74/html5/thumbnails/4.jpg)
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP* et al. Diabetes Care 2012;35:723-730
![Page 5: The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention](https://reader036.vdocuments.us/reader036/viewer/2022062323/5681619a550346895dd14f74/html5/thumbnails/5.jpg)
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP* et al. Diabetes Care 2012;35:723-730
![Page 6: The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention](https://reader036.vdocuments.us/reader036/viewer/2022062323/5681619a550346895dd14f74/html5/thumbnails/6.jpg)
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP* et al. Diabetes Care 2012;35:723-730
![Page 7: The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention](https://reader036.vdocuments.us/reader036/viewer/2022062323/5681619a550346895dd14f74/html5/thumbnails/7.jpg)
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP* et al. Diabetes Care 2012;35:723-730
![Page 8: The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention](https://reader036.vdocuments.us/reader036/viewer/2022062323/5681619a550346895dd14f74/html5/thumbnails/8.jpg)
Conclusions
• Over 10 years, from a payer perspective, lifestyle was cost-
effective and metformin was marginally cost-saving compared with placebo
• Investment in lifestyle and metformin interventions for diabetes
prevention in high-risk adults provides good value for the money spent
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP* et al. Diabetes Care 2012;35:723-730